Live Q&A: A Deeper Dive into NASH Diagnosis and Treatment: An Augmented Reality Experience

Jan
15

Live Q&A: A Deeper Dive into NASH Diagnosis and Treatment: An Augmented Reality Experience

Live Webcast: Monday, February 22, 2021 | 12:00PM – 12:30 PM ET Obesity and diabetes are on the rise, leading to an increased prevalence of non-alcoholic fatty liver disease (NAFLD), which in some cases may progress to non-alcoholic steatohepatitis (NASH). NAFLD affects approximately 30% of the U.S. population, with NASH effecting about 5%.  This live […]

Read More
DETAIL
Oct
30

Live Webcast: All Hands: Integrating a Team Approach to Risk-Benefit Individualization of Rheumatoid Arthritis and Psoriatic Arthritis Therapy

Wednesday, January 27, 2021 | 12:00pm – 1:30pm ET Although rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are associated with irreversible joint damage and physical disability, remission is now an achievable goal for the majority of patients, owing to advances in early diagnosis, new therapies, and improved treatment strategies. This CME Outfitters Live and OnDemand […]

Read More
By Ben Stoner |
DETAIL
Oct
30

Finding Your Footing in the Shifting Landscape of Multiple Sclerosis

In this CME Outfitters Live and OnDemand webcast, animated 3-D models will illustrate the immune processes that contribute to MS pathology and serve as targets for immune-directed therapies. Expert faculty will review clinical data supporting the efficacy and safety of novel and emerging immune-directed therapies as well as the role of biomarkers in assessing disease […]

Read More
By Ben Stoner |
DETAIL
Oct
29

Live Q&A: Laying to Rest Challenges in Managing Excessive Daytime Sleepiness in Patients with Obstructive Sleep Apnea or Narcolepsy – An Augmented Reality Experience

Wednesday, December, 16, 2020 | 12:30 – 1:00pm ET Excessive daytime sleepiness (EDS) is a common symptom of obstructive sleep apnea (OSA) and narcolepsy. EDS is often associated with traffic accidents and occupational incidents, cognitive impairments, and increased risk of medical and psychiatric comorbidities, resulting in poor quality of life (QoL) and increased mortality. Yet, […]

Read More
By Ben Stoner |
DETAIL
Oct
28

Weighing the Evidence: A Pharmacy Approach to Stroke Prevention in Obese Patients with Non-Valvular Atrial Fibrillation

Atrial fibrillation (AF) is estimated to affect over 5 million people in the United States and is associated with a five-fold increase in the relative risk of stroke. Obesity is an independent risk factor for cardiovascular disease (CVD) and is also associated with increased risk of developing non-valvular AF (NVAF). Patients with comorbid NVAF and […]

Read More
By Ben Stoner |
DETAIL
Oct
07

COVID-19 and Its Impact on Patient Care in IBD: What Clinicians Need to Know

This OnDemand webcast provides clinicians with the latest information and consensus recommendations for the management of patients with IBD during the COVID-19 era. Expert faculty will also examine the latest evidence on treatment and prevention strategies for COVID-19.

Read More
By Ben Stoner |
DETAIL
Oct
01

Weighing the Evidence: A Pharmacy Approach to Stroke Prevention in Obese Patients with Non-Valvular Atrial Fibrillation

In this CME Outfitters On Demand webcast, expert faculty review key aspects of the prescribing information, guidelines, and recently published safety and efficacy data for DOACs and warfarin in order to enable pharmacists and other clinicians to support evidence-based therapeutic treatment decisions in obese patients with NVAF.

Read More
By Ben Stoner |
DETAIL
Sep
30

The Role of Antibody Drug Conjugates in Advanced Non-Small Cell Lung Cancer: Guidance for Today and the Path Forward

    In this CME Outfitters OnDemand webcast, integrations of animated 3-D models will provide visual representation of the mechanisms and characteristics of antibody drug conjugates (ADCs) in NSCLC to complement expert faculty insights and evidence supporting testing strategies to identify predictive biomarkers, emerging treatment options for advanced or metastatic NSCLC, and best practices for […]

Read More
DETAIL